Savara Earnings
NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.92+0.09 (+1.86%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Savara earnings summary
In its most recent report on Aug 11, 2026 (Q2 2026), SVRA posted EPS of $-0.16. Across the last 16 reports, SVRA shares moved an average of 7.0% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
SVRA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-0.16 | — | +3.9% |
| May 12, 2026 | — | $-0.15 | — | -0.2% |
| Mar 13, 2026 | — | $-0.13 | — | -5.5% |
| Nov 12, 2025 | — | $-0.14 | — | +14.4% |
| Aug 13, 2025 | — | $-0.14 | — | +3.9% |
| May 13, 2025 | — | $-0.12 | — | -7.5% |
| Mar 27, 2025 | — | $-0.14 | — | -2.1% |
| Nov 12, 2024 | — | $-0.11 | — | +12.8% |
| Aug 12, 2024 | — | $-0.12 | — | +0.5% |
| May 9, 2024 | — | $-0.11 | — | -3.8% |
| Mar 7, 2024 | — | $-0.09 | — | -11.1% |
| Nov 9, 2023 | — | $-0.10 | — | +7.5% |
| Aug 10, 2023 | — | $-0.07 | — | -8.8% |
| May 15, 2023 | — | $-0.07 | — | +1.5% |
| Mar 30, 2023 | — | $-0.07 | — | -11.8% |
| Nov 10, 2022 | — | $-0.07 | — | +17.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.